In this episode of The Upper Brand, Richard Assmus, Kristine Young, and Christa Cole delve into key court cases that have shaped trademark law. They explore the intricacies of functional and generic ...

A U.S. federal judge rejected Novartis' efforts to block the launch of a generic version of Entresto, its blockbuster cardiovascular disease drug, per a FirstWord PHARMA report. The report noted that ...

A federal judge in New Jersey denied a preliminary injunction sought by Novartis (NYSE:NVS) to block MSN Pharmaceuticals from launching a generic version of the former’s blockbuster heart failure ...

Minimally invasive genicular nerve block may be an optimal alternative to surgical procedure as it provides pain relief and functional improvements among patients with knee osteoarthritis. Genicular ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. If the concept of CPU delidding fills you with dread, I think you might also be a little ...

From a tiny sample of tissue no larger than a grain of sand, scientists have come within reach of a goal once thought unattainable: building a complete functional wiring diagram of a portion of the ...

The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto's market exclusivity—took another zig on Thursday with a federal appellate court blocking the sale of a ...

Lupin Pharmaceuticals Inc.'s proposed generic version of an orphan drug to treat ALS infringes five patents owned by Mitsubishi Tanabe Pharma Corp., a federal lawsuit says. Mitsubishi Tanabe alleges ...

Dec 4 (Reuters) - Novartis (NOVN.S), opens new tab failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' blockbuster heart drug Entresto. The ...

Karandeep Singh Oberoi is a Durham College Journalism and Mass Media graduate who joined the Android Police team in April 2024, after serving as a full-time News Writer at Canadian publication ...

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from approving it ...